Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2023 Earnings Conference Call April 26, 2023 8:30 AM ET
Company Participants
Chris Ward – Senior Director-Investor Relations
Jan De Witte – President and Chief Executive Officer
Mathieu Aussermeier – Vice President-FP&A, Investor Relations and Treasurer
Conference Call Participants
Vik Chopra – Wells Fargo
Ryan Zimmerman – BTIG
Craig Bijou – Bank of America
Eric Fleming – Raymond James
Rohan Patel – JPMorgan Chase
Drew Ranieri – Morgan Stanley
Operator
Good day, and thank you for standing by. Welcome to the Integra LifeSciences First Quarter 2023 Financial Results Conference Call. At this time all participants are in a listen-only mode. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your speaker today, Chris Ward, Senior Director of Investor Relations. Please go ahead, sir.
Chris Ward
Thank you, Norma. Good morning, and thank you for joining the Integra LifeSciences first quarter 2023 earnings conference call. Joining me on the call this morning is Jan De Witte, President and Chief Executive Officer; Mathieu Aussermeier, Vice President of FP&A, Investor Relations and Treasurer; and Jeff Mosebrook, Principal Accounting Officer.
Earlier today, we issued a press release announcing our first quarter 2023 financial results. The release and corresponding earnings presentation, which we will reference during the call, are available at integralife.com under Investors, Events and Presentations and a file named First Quarter 2023 Earnings Call Presentation.
Before we begin, I would like to remind you that many of the statements made during this call may be considered forward-looking statements. Factors that could cause actual results to differ materially are discussed in the company’s Exchange Act reports filed with the SEC and in the release. Also in our prepared remarks, we will reference both organic and reported revenue growth. Organic revenue growth excludes the effects of foreign currency, acquisitions, divestitures as well as discontinued products. Unless otherwise stated, all this aggregated and franchise-level revenue growth rates are based on organic performance.
And lastly, our comments today will include certain non-GAAP financial measures. Reconciliations of any non-GAAP financial measures can be found in today’s press release, which is an exhibit to Integra’s current report on Form 8-K filed with the SEC.
And with that, I will now turn the call over to Jan.
Jan De Witte
Thank you, Chris, and good morning, everyone. Let me start by reviewing our first quarter business highlights on Slide 4. Our first quarter revenue performance reflects solid execution by our teams as a positive trend in market demand and procedure volumes that we see now nearing pre-COVID levels.